Baricitinib for Post-HSCT Persistent Thrombocytopenia
Baricitinib for Post-HSCT Persistent Thrombocytopenia
Recruiting · NCT07535645 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Baricitinib for Post-HSCT Persistent Thrombocytopenia | Allogeneic Hematopoietic Stem Cell Transplantation; Persistent Thrombocytopenia | Recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT07535645 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking University People's Hospital | 269 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University People's Hospital | Beijing | China | 146 |